Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

被引：0

作者：

Ho-Young Yhim

Hye Jin Kang

Yoon Hee Choi

Seok Jin Kim

Won Seog Kim

Yee Soo Chae

Jin Seok Kim

Chul Won Choi

Sung Yong Oh

Hyeon Seok Eom

Jeong-A Kim

Jae Hoon Lee

Jong-Ho Won

Hyeok Shim

Je-Jung Lee

Hwa Jung Sung

Hyo Jung Kim

Dae Ho Lee

Cheolwon Suh

Jae-Yong Kwak

机构：

[1] Chonbuk National University Medical School,Department of Internal Medicine

[2] Korea Cancer Center Hospital,Samsung Medical Center

[3] Sungkyunkwan University School of Medicine,Asan Medical Center

[4] Kyungpook National University School of Medicine,undefined

[5] Yonsei University College of Medicine,undefined

[6] Korea University Medical Center,undefined

[7] Guro Hospital,undefined

[8] Dong-A University College of Medicine,undefined

[9] National Cancer Center of Korea,undefined

[10] Catholic University of Korea College of Medicine,undefined

[11] Gachon University Gil Hospital,undefined

[12] Soonchunhyang University College of Medicine,undefined

[13] Wonkwang University School of Medicine,undefined

[14] Chonnam National University Medical School,undefined

[15] Korea University Medical Center,undefined

[16] Ansan Hospital,undefined

[17] Hallym University Medical Center and Hallym University College of Medicine,undefined

[18] University of Ulsan College of Medicine,undefined

来源：

BMC Cancer | / 10卷

关键词：

Overall Survival; International Prognostic Index; Extranodal Lymphoma; Extranodal Disease; Primary Breast Lymphoma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
Bo Jia
Yuankai Shi
Mei Dong
Fengyi Feng
Sheng Yang
Hua Lin
Liqiang Zhou
Shengyu Zhou
Shanshan Chen
Jianliang Yang
Peng Liu
Yan Qin
Changgong Zhang
Lin Gui
Lin Wang
Xue Wang
Xiaohui He
ChineseJournalofCancerResearch, 2014, 26 (04) : 459 - 465
[22] Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lymphoma
Jia, Bo
Shi, Yuankai
Dong, Mei
Feng, Fengyi
Yang, Sheng
Lin, Hua
Zhou, Liqiang
Zhou, Shengyu
Chen, Shanshan
Yang, Jianliang
Liu, Peng
Qin, Yan
Zhang, Changgong
Gui, Lin
Wang, Lin
Wang, Xue
He, Xiaohui
CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 459 - 465
[23] Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial
Sung Yong Oh
Won Seog Kim
Dae Ho Lee
Seok Jin Kim
Sung Hyun Kim
Baek Yeol Ryoo
Hye Jin Kang
Young Jin Choi
Joo Seop Chung
Hyo Jung Kim
Cheolwon Suh
Investigational New Drugs, 2010, 28 : 171 - 177
[24] Consortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea
Kim, Seok Jin
BLOOD RESEARCH, 2015, 50 (04) : 187 - 188
[25] Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial
Oh, Sung Yong
Kim, Won Seog
Lee, Dae Ho
Kim, Seok Jin
Kim, Sung Hyun
Ryoo, Baek Yeol
Kang, Hye Jin
Choi, Young Jin
Chung, Joo Seop
Kim, Hyo Jung
Suh, Cheolwon
INVESTIGATIONAL NEW DRUGS, 2010, 28 (02) : 171 - 177
[26] Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)
Jo, Jae-Cheol
Lee, Ho Sup
Suh, Cheolwon
Kang, Hye Jin
Kim, Won Seog
Eom, HyeonSeok
Kim, Inho
Shin, Ho-Jin
Park, Yong
Lee, Won Sik
Do, Young Rok
Gyeong-Won, Lee
Oh, Sung Yong
Lim, Sung-Nam
Lee, Seong Yoon
BLOOD, 2019, 134
[27] Prognostic factors in diffuse large B-cell lymphoma
Niitsu, Nozomi
INTERNAL MEDICINE, 2006, 45 (05) : 227 - 228
[28] Identification of prognostic factors in patients with diffuse large B-cell lymphoma
Peng, Fang
Guo, Liang
Yao, Wei-Kai
Zheng, Yan
Liu, Ye
Duan, Xiu-Mei
Wang, Yin-Ping
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (01) : 87 - 91
[29] THYROID MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE: CLINICAL MANIFESTATION AND OUTCOME OF A RARE DISEASE-CONSORTIUM FOR IMPROVING SURVIVAL OF LYMPHOMA (CISL) STUDY
Oh, S.
Kim, W.
Kim, J.
Kim, S.
Lee, S.
Lee, D.
Kang, H.
Song, M.
Kim, H.
Kwak, J.
Park, B.
Do, Y.
Jeong, S.
ANNALS OF ONCOLOGY, 2011, 22 : 217 - 217
[30] Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma
Han, Ying
Yang, Jianliang
Liu, Peng
He, Xiaohui
Zhang, Changgong
Zhou, Shengyu
Zhou, Liqiang
Qin, Yan
Song, Yongwen
Sun, Yan
Shi, Yuankai
ONCOLOGIST, 2019, 24 (11): : E1251 - E1261

← 1 2 3 4 5 →